Not applicableApproved For MarketingNCT04972487
What this trial is testing
Expanded Access Program for Tofersen in Participants With Superoxide Dismutase 1-Amyotropic Lateral Sclerosis
Who this might be right for
Superoxide Dismutase 1-Amyotropic Lateral Sclerosis
Biogen